National Advertising Division Refers Advertising Claims for Gravity Defyer Shoes to Federal Trade Commission for Possible Enforcement Action
NEWYORK, Sept. 14, 2021 /PRNewswire/ --The National Advertising Division (NAD) of BBB National Programs is disappointed that Gravity Defyer Medical Technology Corporation declined to participate in the industry self-regulation process.
- NEWYORK, Sept. 14, 2021 /PRNewswire/ --The National Advertising Division (NAD) of BBB National Programs is disappointed that Gravity Defyer Medical Technology Corporation declined to participate in the industry self-regulation process.
- As a result of the advertiser's failure to participate, NAD has referred advertising claims for their Gravity Defyer shoes to the Federal Trade Commission (FTC) for review.
- In 2019, NAD requested that Gravity Defyer Medical Technology Corporation provide evidence that it complied with a 2011 NAD decision to discontinue certain health-related claims for Gravity Defyer shoes.
- About the National Advertising Division:TheNational Advertising Division (NAD) of BBB National Programsprovidesindependent self-regulationand dispute resolution services,guidingthe truthfulness of advertising across the U.S. NADreviews national advertising in all media and its decisions set consistent standards foradvertisingtruth and accuracy, delivering meaningful protection toconsumersand leveling the playing field for business.